Canada markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.3650-0.0350 (-1.46%)
At close: 04:00PM EDT
2.3600 -0.01 (-0.21%)
After hours: 04:06PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-190,099
-234,632
-183,118
-250,219
-204,472
Depreciation & amortization
20,234
20,250
18,020
13,624
4,294
Stock based compensation
56,984
47,084
81,924
62,201
33,261
Change in working capital
-41,694
3,421
-82,015
4,015
-336
Accounts Payable
513
1,464
667
91
-278
Other working capital
-170,569
-166,380
-193,831
-191,753
-212,355
Other non-cash items
-12,409
-4,653
-6,683
4,624
12,047
Net cash provided by operating activites
-163,326
-163,694
-169,555
-126,249
-160,874
Cash flows from investing activities
Investments in property, plant and equipment
-7,243
-2,686
-24,276
-65,504
-51,481
Purchases of investments
-279,764
-476,880
-406,316
-673,465
-908,357
Sales/Maturities of investments
618,393
663,614
419,052
617,396
686,322
Net cash used for investing activites
331,386
184,048
-11,540
-121,573
-273,516
Cash flows from financing activities
Common stock issued
-
0
0
391,802
0
Common stock repurchased
-
-
0
0
-16,050
Other financing activites
-428
-457
-461
-
-
Net cash used privided by (used for) financing activities
1,847
1,743
10,635
401,244
476,790
Net change in cash
169,907
22,097
-170,460
153,422
42,400
Cash at beginning of period
116,590
123,834
294,294
140,872
98,472
Cash at end of period
286,497
145,931
123,834
294,294
140,872
Free Cash Flow
Operating Cash Flow
-163,326
-163,694
-169,555
-126,249
-160,874
Capital Expenditure
-7,243
-2,686
-24,276
-65,504
-51,481
Free Cash Flow
-170,569
-166,380
-193,831
-191,753
-212,355